A Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Treatment-resistant Depression

A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects with Treatment-resistant Depression

Addendum No 01 zu einer interventionellen Studie

Addendum No 01 zu einer interventionellen Studie

ECLIPSE – Interventionelle Studie

GMMG-DANTE

POLARIS – Addendum zu interventionellen Studie

POLARIS – Interventionelle Studie

POLARIS – Interventionelle Studie

Symposium 2015 – 9. Jahressymposium INDIRA

Symposium des Leberzentrums Tübingen

Veranstaltung – Hepatologie Update 2016